跳至主要内容
临床试验/CTRI/2022/07/044210
CTRI/2022/07/044210已完成4 期

EFFICACY OF KAISHORA GUGGULU AFTER VIRECHANA AS AN ADD- ON TO THE STANDARD OF CARE IN MANAGEMENT OF DIABETIC PERIPHERAL NEUROPATHY : A PRE AND POST TEST CLINICAL STUDY ?

Dr VEENA VASUDEVA0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Diagnosed cases of DSPN ( who fulfil the diagnostic criteria )
  • ? Participants with HbA1c value between 7 and 8
  • ? Patients up to the stage of N2a i.e., stage of mild diabetic polyneuropathy is needed to
  • be considered
  • ? Participants from whom the written consent is obtained

排除标准

  • Those with CAD, retinopathy , nephropathy diseases Those with alcoholic, smoking
  • ? Participants who are having other systemic diseases.
  • ? Patients having foot ulcer, cellulitis.
  • ? Patient who suffer with N2b stage i.e Severe diabetic polyneuropathy
  • ? Participants with HbA1C value more than 8 mg/dl
  • ? Serum Creatinine value more than 1.1mg/dl

研究者

发起方
Dr VEENA VASUDEVA

相似试验